Vitamin D Deficiency Increases Severity of Paclitaxel-Induced Peripheral Neuropathy

PURPOSE: Approximately 25% of patients receiving weekly paclitaxel for breast cancer require treatment disruptions to avoid severe, irreversible peripheral neuropathy (PN). Vitamin insufficiencies are PN risk factors in many diseases, but their relevance to chemotherapy-induced PN is unknown. METHOD...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Main Authors: Jennaro, Theodore, Fang, Fang, Kidwell, Kelley M, Lavoie Smith, Ellen M., Vangipuram, Kiran, Burness, Monika L, Griggs, Jennifer J., Van Poznak, Catherine, Hayes, Daniel F., Henry, N. Lynn, Hertz, Daniel L.
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7945004/
https://ncbi.nlm.nih.gov/pubmed/32166478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05584-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares